PepGen PEPG
NASDAQ PEPG
$2.34 -0.25 (-9.65%)
At close: Sep 29, 2026 · 4:00 PM EDT

PepGen (PEPG) Cash from Restructuring (2022 - 2025)

Updated

PepGen's Cash from Restructuring came in at -$11,000 for Q2 2025.

Analysis

PepGen (PEPG) Cash from Restructuring (2022 - 2025) Analysis & Trends

For FY2024, PepGen's Cash from Restructuring was $70,000.

  • Going back by year, Cash from Restructuring was $134,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 PepGen 179.38 Mn 179.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 50,000.00
Mar 31, 2024 20,000.00
Dec 31, 2022 -2,000.00
API Access

PepGen Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=PEPG&period=max&api_key=YOUR_API_KEY